Results 91 to 100 of about 7,482 (199)

Extrapolating Survival from Randomized Trials Using External Data: A Review of Methods. [PDF]

open access: yes, 2016
This article describes methods used to estimate parameters governing long-term survival, or times to other events, for health economic models. Specifically, the focus is on methods that combine shorter-term individual-level survival data from randomized ...
Bojke, Laura   +6 more
core   +4 more sources

SUGAMMADEX versus neostigmine after ROCURONIUM continuous infusion in patients undergoing liver transplantation [PDF]

open access: yes, 2020
Background: Rapid neuromuscular block reversal at the end of major abdominal surgery is recommended to avoid any postoperative residual block. To date, no study has evaluated sugammadex performance after rocuronium administration in patients undergoing ...
Barbariol, F.   +4 more
core   +1 more source

Caracterização da Utilização de Sugamadex no Centro Hospitalar de Lisboa Central - Hospital de S. José [PDF]

open access: yes, 2015
Introdução O sugamadex é uma gama ciclodextrina modificada que forma um complexo com os bloqueadores neuromusculares rocurónio e vecurónio, revertendo o bloqueio neuromuscular (BNM) induzido por estes fármacos1,2,3,4.
Antas, T   +4 more
core  

A retrospective cohort study [PDF]

open access: yes, 2021
학위논문 (박사) -- 서울대학교 대학원 : 의과대학 의학과, 2021. 2. 오아영.Background: The use of sugammadex can reduce post-operative residual neuromuscular blockade, which is known to increase the risk of post-operative respiratory events.
한지원
core  

Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports

open access: yesBMC Anesthesiology, 2019
Background Sugammadex is a modified gamma-cyclodextrin that acts by selectively encapsulating free amino-steroidal neuromuscular relaxants. Several case reports have been published on the use of sugammadex in patients with neuromuscular disorders that ...
Usha Gurunathan   +2 more
doaj   +1 more source

Yleisanestesian pika-induktio ja hengitystien turvaaminen [PDF]

open access: yes, 2017
Teema : vatsaelinkirurginen ...
Liuhanen, Sasu, Niemi-Murola, Leila
core  

Sugammadex-Enhanced Neuronal Apoptosis following Neonatal Sevoflurane Exposure in Mice

open access: yesAnesthesiology Research and Practice, 2016
In rodents, neonatal sevoflurane exposure induces neonatal apoptosis in the brain and results in learning deficits. Sugammadex is a new selective neuromuscular blockade (NMB) binding agent that anesthesiologists can use to achieve immediate reversal of ...
Maiko Satomoto   +3 more
doaj   +1 more source

ROCURONIUM-INDUCED ANAPHYLAXIS: ANY EVIDENCE FOR SUGAMMADEX? [PDF]

open access: yes, 2023
INTRODUCTION: Anaphylaxis during general anesthesia is estimated to occur around 1 in 3,500 cases. 90% of these cases occur at induction of anesthesia. Neuromuscular blocking drugs are thought to be the most responsible trigger, with Rocuronium being the
Elmer, Warren   +5 more
core   +1 more source

Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series

open access: yesBMC Anesthesiology
Background Sugammadex is a pharmacologic agent that provides rapid reversal of neuromuscular blockade via encapsulation of the neuromuscular blocking agent (NMBA).
Sindhu N. Samba   +5 more
doaj   +1 more source

Airway Management of Hypokalaemic Paralysis with Trismus and Bulbar Palsy Due To Conn's Syndrome

open access: yes
The Laryngoscope, Volume 135, Issue 6, Page 2070-2072, June 2025.
Cristian Aragón‐Benedí   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy